Roivant Sciences ROIV
NASDAQ ROIV
$36.57 +0.07 (+0.19%)
At close: Sep 30, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Capital Expenditures (2020 - 2026)

Updated

Roivant Sciences' Capital Expenditures came in at $419,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 89.6% from $4.04 million a year earlier and down 66.8% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Capital Expenditures (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Roivant Sciences reported Capital Expenditures of $4.59 million, down 40.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $8.21 million, up 78.5% from FY2025.

  • Capital Expenditures carries a five-year compound annual growth rate of 7.2% (FY2021 to FY2026).
  • Going back by fiscal year, Capital Expenditures was $4.6 million in FY2025 (+232.8%), $1.38 million in FY2024 (-89.1%), $12.69 million in FY2023 (-27.2%) and $17.44 million in FY2022 (+200.3%).
  • The five-year range for quarterly Capital Expenditures is -$4.94 million (fiscal Q3 2026) to $7.85 million (fiscal Q2 2026).
  • Year-over-year, Capital Expenditures increased in six of the last seven quarters, with growth averaging 254.5%.
  • The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q2 2026 (growth of 688.0%), and the weakest in fiscal Q1 2024 (a decline of 94.6%).
  • Business Quant data shows ROIV's Capital Expenditures at $1.26 million (Q4 2026), -$4.94 million (Q3 2026) and $7.85 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Roivant Sciences 26.38 Bn 27.07 Bn 1.16 Mn 419,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 419,000.00
Mar 31, 2026 1.26 Mn
Dec 31, 2025 -4.94 Mn
Sep 30, 2025 7.85 Mn
Jun 30, 2025 4.04 Mn
Mar 31, 2025 811,000.00
Dec 31, 2024 1.83 Mn
Sep 30, 2024 996,000.00
Jun 30, 2024 965,000.00
Mar 31, 2024 349,000.00
Dec 31, 2023 355,000.00
Sep 30, 2023 275,000.00
Jun 30, 2023 403,000.00
Mar 31, 2023 1.62 Mn
Dec 31, 2022 508,000.00
Sep 30, 2022 3.10 Mn
Jun 30, 2022 7.46 Mn
Mar 31, 2022 6.26 Mn
Dec 31, 2021 6.07 Mn
Sep 30, 2021 2.76 Mn
API Access

Roivant Sciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ROIV&period=max&api_key=YOUR_API_KEY